AXNX - Axonics Modulation Technologies GAAP EPS of -$0.50 beats by $0.13 revenue of $48.42M beats by $3.05M
Axonics Modulation Technologies press release (NASDAQ:AXNX): Q1 GAAP EPS of -$0.50 beats by $0.13. Revenue of $48.42M (+40.9% Y/Y) beats by $3.05M. FY22 Outlook: Total company revenue of $238M, an increase of 32% compared to FY21 revenue. This compares to prior revenue guidance of $234M; Sacral neuromodulation revenue of $199M (+26% Y/Y); Bulkamid revenue of $39M (+72% Y/Y).
For further details see:
Axonics Modulation Technologies GAAP EPS of -$0.50 beats by $0.13, revenue of $48.42M beats by $3.05M